NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

NRx Pharmaceuticals Inc (NASDAQ: NRXP)

 
NRXP Technical Analysis
5
As on 25th Jan 2022 NRXP Share Price closed @ 3.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 23.01 & Strong Sell for SHORT-TERM with Stoploss of 11.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NRXP Share Price

Open 3.04 Change Price %
High 3.20 1 Day 0.03 0.96
Low 2.97 1 Week -1.22 -27.79
Close 3.17 1 Month -2.72 -46.18
Volume 406590 1 Year -7.61 -70.59
52 Week High 62.71 | 52 Week Low 3.14
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
NRXP
Daily Charts
NRXP
Intraday Charts
Whats New @
Bazaartrend
NRXP
Free Analysis
 
NRXP Important Levels Intraday
RESISTANCE3.61
RESISTANCE3.47
RESISTANCE3.38
RESISTANCE3.30
SUPPORT3.04
SUPPORT2.96
SUPPORT2.87
SUPPORT2.73
 
NRXP Target for Month January
4th UP TARGET54.56
3rd UP TARGET38.08
2nd UP TARGET27.89
1st UP TARGET17.71
1st DOWN TARGET-11.37
2nd DOWN TARGET-21.55
3rd DOWN TARGET-31.74
4th DOWN TARGET-48.22
 
NRXP Weekly Target
4th UP TARGET3.29
3rd UP TARGET3.25
2nd UP TARGET3.23
1st UP TARGET3.20
1st DOWN TARGET3.14
2nd DOWN TARGET3.11
3rd DOWN TARGET3.09
4th DOWN TARGET3.05
 
NRXP Target for Year 2022
4th UP TARGET146.04
3rd UP TARGET100.22
2nd UP TARGET71.9
1st UP TARGET43.58
1st DOWN TARGET-37.24
2nd DOWN TARGET-65.56
3rd DOWN TARGET-93.88
4th DOWN TARGET-139.7
 
 
NRXP Other Details
Segment EQ
Market Capital 536121824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NRXP Address
NRXP
 
NRXP Latest News
 
Your Comments and Response on NRx Pharmaceuticals Inc
 
NRXP Business Profile
NRX Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company's pipeline includes medicinal candidates in Phase 2 and Phase 3 trials for COVID-19-related lung injury and acute respiratory distress. Its products include ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure; and NRX-100/101, an investigational pre-commercial drug for treating bipolar depression in patients with acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware. Address: 1201 Orange Street, Wilmington, DE, United States, 19801
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service